Biotechnology Industry Market Index
The Biotechnology Industry in the Health Care Sector includes companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering (including companies specializing in protein-based therapeutics to treat human diseases).
The Biotechnology industry index is a market composite index that includes 8 stocks from public trading companies and ADRs with the largest market capitalizations in the Biotechnology industry.
The list of stocks in the Biotechnology industry includes Amgen Inc, Vertex Pharmaceuticals Inc, Biogen Inc, Incyte Corp, Alexion Pharmaceuticals Inc, Gilead Sciences Inc, AbbVie Inc and Regeneron Pharmaceuticals Inc.
5/7/2021 Health Care Sector Biotechnology Industry
$247,677
Change: +0.29%
Open: $247,246
High: $250,219
Low: $245,898
| Amgen Inc (AMGN) |
+1.16%
|
| Vertex Pharmaceuticals Inc (VRTX) |
+0.87%
|
| Biogen Inc (BIIB) |
+0.71%
|
| Incyte Corp (INCY) |
+0.52%
|
| Alexion Pharmaceuticals Inc (ALXN) |
+0.34%
|
| Biotechnology Industry |
+0.29%
|
| Gilead Sciences Inc (GILD) |
+0.00%
|
| AbbVie Inc (ABBV) |
-0.28%
|
| Regeneron Pharmaceuticals Inc (REGN) |
-0.39%
|
Index Value: $247,677 +0.29%
Volume: 7.53B Average Volume (3 month): 9.70B
Market Capitalization: $227.77T
EBITDA: $26.62T
EPS Basic: $3,744 Diluted: $3,744 Actual: $5,228
EPS Estimation: High $5,829 Medium: $5,112 Low: $4,555
EPS TTM: $8,797
P/E: 28.16
PEG Ratio (5 year Expected): 1.92
Dividend Yield: 2.14%
Dividend Rate: $5,300
Dividend Yield (Forward): 2.63%
Dividend Rate (Forward): $6,503
Shares Outstanding: 2.02T
Book Value: $33,892
Short Ratio: 3.06
Price Target (1 year): $272,938
Volume: 7.53B Average Volume (3 month): 9.70B
Market Capitalization: $227.77T
EBITDA: $26.62T
EPS Basic: $3,744 Diluted: $3,744 Actual: $5,228
EPS Estimation: High $5,829 Medium: $5,112 Low: $4,555
EPS TTM: $8,797
P/E: 28.16
PEG Ratio (5 year Expected): 1.92
Dividend Yield: 2.14%
Dividend Rate: $5,300
Dividend Yield (Forward): 2.63%
Dividend Rate (Forward): $6,503
Shares Outstanding: 2.02T
Book Value: $33,892
Short Ratio: 3.06
Price Target (1 year): $272,938
| Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
| AMGN | Amgen Inc | 254.21 | +1.16% | 2.46M | 0.90 | 22.83% |
| VRTX | Vertex Pharmaceuticals Inc | 215.01 | +0.87% | 1.07M | 0.57 | 8.70% |
| BIIB | Biogen Inc | 274.04 | +0.71% | 905,746 | 0.82 | 6.45% |
| INCY | Incyte Corp | 82.74 | +0.52% | 1.05M | 0.81 | 2.84% |
| ALXN | Alexion Pharmaceuticals Inc | 170.43 | +0.34% | 1.17M | 0.49 | 5.89% |
| Biotechnology Industry | 247,676.55 | +0.29% | 7.53B | 0.78 | 10.45% | |
| GILD | Gilead Sciences Inc | 66.54 | +0.00% | 5.69M | 0.73 | 13.09% |
| ABBV | AbbVie Inc | 115.75 | -0.28% | 5.61M | 0.81 | 31.93% |
| REGN | Regeneron Pharmaceuticals Inc | 496.75 | -0.39% | 689,368 | 0.72 | 8.27% |
| Symbol | Security | Market Cap | EPS TTM | P/E | Div Yield | PEG Ratio |
| AMGN | Amgen Inc | 146.057B | $12.07 | 21.06 | 2.61% | 2.47 |
| VRTX | Vertex Pharmaceuticals Inc | 55.659B | $10.50 | 20.48 | 1.53 | |
| BIIB | Biogen Inc | 41.258B | $19.06 | 14.38 | -1.19 | |
| INCY | Incyte Corp | 18.196B | $2.17 | 38.13 | 1.35 | |
| ALXN | Alexion Pharmaceuticals Inc | 37.668B | $3.06 | 55.70 | 1.46 | |
| Biotechnology Industry | $227.77T | $8,797 | 28.16 | 2.14% | 1.92 | |
| GILD | Gilead Sciences Inc | 83.778B | $0.23 | 289.30 | 4.13% | 3.13 |
| ABBV | AbbVie Inc | 204.208B | $2.83 | 40.90 | 3.15% | 2.11 |
| REGN | Regeneron Pharmaceuticals Inc | 52.915B | $35.33 | 14.06 | 1.10 | |
Back to Market Summary